Late-Model Equipment from Merck and Industry Leaders Available for Bidding June 23–25, 2025
EquipNet, a global leader in surplus asset management, is pleased to announce a major online auction running from June 23 to 25, 2025. This highly anticipated sale features premium new, used, and late-model equipment from major vaccine and gene therapy manufacturers, including Merck, with contributions from leading brands such as Cytiva, Sartorius, Millipore, Thermo, and Agilent. With some assets still in original OEM packaging, this is a rare opportunity for biotech and pharmaceutical manufacturers to access high-end equipment at exceptional value.
The auction includes a wide selection of high-performance machinery ideal for advanced biologics, vaccine production, and cell & gene therapy workflows. Key assets include:
- Cytiva GE AKTA ReadyFlux XL tangential flow filtration system
- GEA Westfalia CSC-15 centrifuge separation skid
- Unused Cytiva XDR50 bioreactor
- GE Healthcare Bio-Sciences AKTA process chromatography skid
- Thermo HyPerforma 2000 liter single use bioreactor
- Thermo Scientific 3000 liter single use mix tank – SUM
- Thermo Scientific SUB-2040-02 Hyperforma controller
- Thermo Fisher 200 liter jacketed single use mixer – SUM
This auction is tailored for companies looking to scale their biologics or gene therapy production capacity without the extended lead times and capital expense of new procurement. With assets sourced from globally respected manufacturers, buyers can invest in reliable and cutting-edge solutions suited for GMP environments.
EquipNet is the world’s leading provider of surplus asset management solutions. Serving clients across biotechnology, pharmaceutical, and manufacturing industries, EquipNet delivers flexible services for buying, selling, and managing used equipment. Their global marketplace and auction services make high-value assets accessible to businesses of all sizes, ensuring seamless transactions and verified quality every step of the way.
To register or view the full catalog, visit